VANCOUVER, CANADA – November 3, 2020 – Evasc has announced that Dr. Martin Rothman has joined its Board of Directors. Dr. Rothman is an experienced executive who brings to Evasc his expertise as founder, Director and supporter of a number of medical device companies. Dr. Rothman was the Vice President of medical affairs for coronary, structural heart and renal denervation for Medtronic, based in Santa Rosa (CA). Dr. Rothman previously practiced for 37 years in the U.K. as an interventional cardiologist, including 27 years at the London Chest Hospital (Barts and the London NHS Trust), where he served for more than a decade as director of cardiac research and development.
“I am pleased to announce that Dr. Martin Rothman will be joining our Board. He brings Evasc a very broad knowledge of vascular business, with extensive clinical and regulatory experience that will help advance our commercial and regulatory strategy”, said Dr. Donald Ricci, President and Chief Executive Officer of Evasc.
eCLIPs is a non-tubular endovascular device currently targeted for use in challenging wide-neck bifurcations, but whose technology is designed to treat 95% of cerebral aneurysm cases. eCLIPs’ unique design provides not only coil retention, but also flow diversion at the neck. eCLIPs avoids dangerous entry into the dynamic, fragile environment of the aneurysm sac while leaving side branches unencumbered and providing a platform for endothelial growth across the bifurcation neck.
Evasc is a privately-held medical device company focused on the development of disruptive endovascular treatments for cerebral aneurysms. Evasc is headquartered in Vancouver, Canada.
Evasc is on the web at www.evasc.com.
For more information, contact Scott Wilson at +1 (604) 742-3811, email@example.com.